Merit Medical Systems Inc (MMSI)
85.63
-0.32
(-0.37%)
USD |
NASDAQ |
Jul 01, 14:20
Merit Medical Systems Research and Development Expense (Annual): 84.28M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 84.28M |
| December 31, 2022 | 82.18M |
| December 31, 2021 | 71.25M |
| December 31, 2020 | 57.79M |
| December 31, 2019 | 66.14M |
| December 31, 2018 | 60.18M |
| December 31, 2017 | 63.54M |
| December 31, 2016 | 45.69M |
| December 31, 2015 | 41.81M |
| December 31, 2014 | 36.63M |
| December 31, 2013 | 33.89M |
| December 31, 2012 | 30.24M |
| December 31, 2011 | 27.78M |
| December 31, 2010 | 15.34M |
| December 31, 2009 | 11.17M |
| Date | Value |
|---|---|
| December 31, 2008 | 9.16M |
| December 31, 2007 | 8.688M |
| December 31, 2006 | 8.582M |
| December 31, 2005 | 6.992M |
| December 31, 2004 | 5.079M |
| December 31, 2003 | 4.626M |
| December 31, 2002 | 4.008M |
| December 31, 2001 | 4.118M |
| December 31, 2000 | 3.864M |
| December 31, 1999 | 3.60M |
| December 31, 1998 | 3.20M |
| December 31, 1997 | 4.40M |
| December 31, 1996 | |
| December 31, 1995 | 2.30M |
| December 31, 1994 | 2.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
57.79M
Minimum
2020
84.28M
Maximum
2023
72.33M
Average
71.25M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Becton Dickinson & Co | 1.237B |
| ResMed Inc | 287.64M |
| Stryker Corp | 1.388B |
| Perspective Therapeutics Inc | 21.31M |